✦ LIBER ✦

Regulatory issues facing the development of drug-eluting stents: a US FDA perspective

✍ Scribed by Boam, Ashley B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE DEVELOPMENT OF A NUMERICAL MASS TRAN

✍ Barry M O'Connell; Tim M McGloughlin; Michael T Walsh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 100 KB

1040-73 Financial impact of drug-eluting

✍ David S Marks; Thomas A Ratko; Karl A Matuszewski; Michael J Oinonen; Joseph P C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 94 KB

TCT-274: The Use of a Different Drug Elu

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Developing new drugs for the treatment o

✍ Leonard V. Sacks; Rachel E. Behrman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Regulatory Perspectives on Pharmacogenom

✍ Phillips, K. A. 📂 Article 📅 2006 🏛 SAGE Publications 🌐 English ⚖ 149 KB

Late stent thrombosis: Considerations an

✍ John McB. Hodgson; Gregg W. Stone; A. Michael Lincoff; Lloyd Klein; Howard Walpo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views